Research analysts at LADENBURG THALM/SH SH started coverage on shares of Allarity Therapeutics (NASDAQ:ALLR – Get Rating) in a research note issued to investors on Friday, The Fly reports. The brokerage set a “buy” rating on the stock.
Research analysts at LADENBURG THALM/SH SH started coverage on shares of Allarity Therapeutics (NASDAQ:ALLR – Get Rating) in a research note issued to investors on Friday, The Fly reports. The brokerage set a “buy” rating on the stock.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.